Cardiovascular Health

For cardiovascular health we model and predict the 15-year probability of a Major Adverse Cardiac Event (MACE). We utilize MACE3 which includes all myocardial infarctions (or heart attacks), all strokes (hemorrhagic and ischemic) and complications following these events, resulting in cardiovascular mortality . Below are values of our model’s most predictive biomarkers for MACE in males and females aged 55 to 70 with no prior history of MACE.

The tables below contain cardiovascular health risk multipliers (RM) for each of the above biomarkers.

---

_{© 2026 Volo Health, LLC. All rights reserved. VOLO™ is a trademark of Volo Health, LLC. All other trademarks, service marks, trade names, and logos are the property of their respective owners.}